These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 36605616)

  • 1. Functions and dysfunctions of oligodendrocytes in neurodegenerative diseases.
    Han S; Gim Y; Jang EH; Hur EM
    Front Cell Neurosci; 2022; 16():1083159. PubMed ID: 36605616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Astrocytes and microRNA Dysregulation in Neurodegenerative Diseases: From Pathogenesis to Therapeutic Potential.
    Bai Y; Su X; Piao L; Jin Z; Jin R
    Front Mol Neurosci; 2021; 14():556215. PubMed ID: 33815055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White Matter Damage in Alzheimer's Disease: Contribution of Oligodendrocytes.
    Zhou J; Zhang P; Zhang B; Kong Y
    Curr Alzheimer Res; 2022 Oct; 19(9):629-40. PubMed ID: 36281858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyroptosis in neurodegenerative diseases: from bench to bedside.
    Wu KJ; Wang WR; Cheng QH; Li H; Yan WZ; Zhou FR; Zhang RJ
    Cell Biol Toxicol; 2023 Dec; 39(6):2467-2499. PubMed ID: 37491594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory mechanism of cyclins and cyclin-dependent kinases in post-mitotic neuronal cell division.
    Gupta R; Jha A; Ambasta RK; Kumar P
    Life Sci; 2021 Nov; 285():120006. PubMed ID: 34606852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?
    Ettle B; Schlachetzki JCM; Winkler J
    Mol Neurobiol; 2016 Jul; 53(5):3046-3062. PubMed ID: 25966971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Perspectives on Gene Therapy Delivery for Neurodegenerative and Neuromuscular Disorders.
    Gomez Limia C; Baird M; Schwartz M; Saxena S; Meyer K; Wein N
    J Pers Med; 2022 Nov; 12(12):. PubMed ID: 36556200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid Peroxidation and Antioxidant Supplementation in Neurodegenerative Diseases: A Review of Human Studies.
    Petrovic S; Arsic A; Ristic-Medic D; Cvetkovic Z; Vucic V
    Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33202952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Emerging Role of Circular RNAs in Alzheimer's Disease and Parkinson's Disease.
    Zhang M; Bian Z
    Front Aging Neurosci; 2021; 13():691512. PubMed ID: 34322012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Gene Therapy Approaches for Targeting Neurodegenerative Disorders: Focusing on Delivering Neurotrophic Genes.
    Kumari S; Kamiya A; Karnik SS; Rohilla S; Dubey SK; Taliyan R
    Mol Neurobiol; 2024 Jun; ():. PubMed ID: 38856793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligodendrocytes and myelin: Active players in neurodegenerative brains?
    Chen JF; Wang F; Huang NX; Xiao L; Mei F
    Dev Neurobiol; 2022 Mar; 82(2):160-174. PubMed ID: 35081276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Neuropharmacological Evaluation of Seaweed: A Potential Therapeutic Source.
    Jannat K; Balakrishnan R; Han JH; Yu YJ; Kim GW; Choi DK
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligodendrocyte Development and Regenerative Therapeutics in Multiple Sclerosis.
    Gacem N; Nait-Oumesmar B
    Life (Basel); 2021 Apr; 11(4):. PubMed ID: 33918664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNAs in Neurodegenerative Diseases: Pathogenesis and Potential Implications as Clinical Biomarkers.
    Zhang M; He P; Bian Z
    Front Mol Neurosci; 2021; 14():685143. PubMed ID: 34421536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems modeling of metabolic dysregulation in neurodegenerative diseases.
    Baloni P; Funk CC; Readhead B; Price ND
    Curr Opin Pharmacol; 2021 Oct; 60():59-65. PubMed ID: 34352486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies.
    Tognatta R; Miller RH
    Neuropharmacology; 2016 Nov; 110(Pt B):539-547. PubMed ID: 27108096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria targeting drugs for neurodegenerative diseases-Design, mechanism and application.
    Xu J; Du W; Zhao Y; Lim K; Lu L; Zhang C; Li L
    Acta Pharm Sin B; 2022 Jun; 12(6):2778-2789. PubMed ID: 35755284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between CNS-active drugs and risk of Alzheimer's and age-related neurodegenerative diseases.
    Cortes-Flores H; Torrandell-Haro G; Brinton RD
    Front Psychiatry; 2024; 15():1358568. PubMed ID: 38487578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of triggering receptor expressed on myeloid cells 2 (TREM2) in neurodegenerative dementias.
    Shafi S; Singh A; Ibrahim AM; Alhajri N; Abu Izneid T; Pottoo FH
    Eur J Neurosci; 2021 May; 53(10):3294-3310. PubMed ID: 33786894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.